Lipoprotein(a) test: what Lp(a) is, normal range and price

A lipoprotein(a) test, usually written Lp(a), measures an LDL-like particle whose level is set mostly by the genes you inherit. Diet and exercise barely move it, so for most adults one measurement is enough. European and US guidelines now recommend measuring it at least once in every adult's lifetime, because a high level adds to cardiovascular risk even when the rest of the cholesterol result looks fine.

What Lp(a) measures

Lp(a) is built like an LDL particle, carrying ApoB, with an extra protein attached called apolipoprotein(a). More than 90% of the difference in Lp(a) between people comes from variation at the LPA gene. That gene is fully active by age 2, and adult levels are usually reached by about age 5, although they can keep rising into adulthood.

Genetic and observational studies show that a high Lp(a) is a cause, not just a marker, of atherosclerotic heart and artery disease and of narrowing of the aortic valve. Risk climbs steadily as the level rises rather than switching on at one number. Lp(a) is not part of a standard lipid profile and has to be ordered as a separate test. The cholesterol it carries is counted inside the LDL cholesterol figure on a standard report, which cannot separate the two.

Lp(a) normal range

Lp(a) is reported either in nmol/L, which counts particles and is the unit the European Atherosclerosis Society prefers, or in mg/dL, which weighs them. There is no exact conversion between the two, because assays differ; a factor of 2 to 2.5 nmol/L per mg/dL is a rough guide at most. Thresholds also differ slightly between guidelines.

Lp(a)	nmol/L	mg/dL	What guidelines say
Low	below 75	below 30	EAS 2022: Lp(a)-related risk ruled out
Grey zone	75 to 125	30 to 50	EAS 2022: weigh with other risk factors
Raised	above 125	above 50	EAS 2022: raised risk ruled in; ACC/AHA 2026: about 1.4 times the risk
High	above 250	above 100	ACC/AHA 2026: at least double the risk
Very high	430 or above	180 or above	ESC/EAS 2019: lifetime risk similar to inherited high cholesterol

The 2025 European update treats a level above 50 mg/dL (105 nmol/L) as a factor that can move someone into a higher risk group. In a typical Western or Northern European population, about 20% of adults have an Lp(a) of 50 mg/dL or more. Women's levels run about 5 to 10% higher than men's on average. Ranges also vary by laboratory and method, so read your result against the range on your own report.

What a high Lp(a) usually points to

A high Lp(a) usually reflects inheritance rather than lifestyle. It points to a higher lifetime chance of heart attack, stroke and aortic valve narrowing, added on top of whatever other risk factors a person has. It raises the odds rather than settling the outcome, and it is not a diagnosis.

The European Atherosclerosis Society's 2022 consensus, written when no medicine aimed at Lp(a) itself had been approved, advises early and thorough attention to the risks that can be changed, judged against a person's overall risk: LDL cholesterol, blood pressure, blood sugar and lifestyle. The 2026 US guideline likewise says people with a raised Lp(a) should be offered early options for reducing their cardiovascular risk. A doctor will usually read it with ApoB and LDL cholesterol, and may suggest testing close relatives, since a high level runs in families.

What a low Lp(a) usually points to

A low Lp(a) means this inherited factor is not adding to your risk. Most people have relatively low levels. Some studies link very low levels with a higher chance of type 2 diabetes, an association the European consensus describes as worth further study.

What moves Lp(a)

• Genes. They set most of it, which is why a single result usually holds. Within one person, levels typically vary by less than 10% over time.
• Food and exercise. Lifestyle changes have minimal effect. Some diet changes shift it by about 10 to 15% either way, fasting makes no difference, and physical activity little or none.
• Pregnancy. Lp(a) can roughly double during pregnancy.
• Thyroid, kidney and liver. An underactive thyroid raises Lp(a). Kidney disease that leaks protein can raise it several times over, while liver disease can lower it, since the liver makes it.
• Illness and inflammation. Several inflammatory conditions raise it, while severe acute illness such as sepsis can lower it.
• Medicines. Statins may raise Lp(a) slightly, some other cholesterol-lowering medicines lower it by 15 to 30%, and hormone therapy after menopause lowers it by about a quarter. If you take any of these, mention it, and take any question about treatment to your doctor with the result in front of you.
• The assay. Some assays read high or low depending on the size of the apolipoprotein(a) protein, so the EAS asks laboratories to name the assay on the report.

Preparing for an Lp(a) test

Lp(a) is not affected by food, so this marker on its own does not need fasting, although MedlinePlus notes that some labs still ask for a fast of 9 to 12 hours. In a panel that also includes fasting glucose and fasting insulin, you fast anyway. Tell the person taking the sample about a pregnancy, a recent illness, any kidney, liver or thyroid condition, and any niacin, aspirin, oral oestrogen or regular alcohol, which MedlinePlus lists as things that can affect the result.

How Clare's panel handles Lp(a)

In Clare's panel, Lp(a) is measured by the lab, alongside ApoB and the standard lipid profile. That matters because it is the lipid marker a standard profile never shows, and because it changes how the rest of the result is read: an LDL or ApoB that looks moderate means something different next to a high Lp(a).

Why it matters in the UAE

UAE data are still limited. At Cleveland Clinic Abu Dhabi, 5,677 patients had Lp(a) measured between July 2017 and October 2023, fewer than 1% of the patients seen there. Their median was 32 nmol/L, and 15.9% of tests came back above 125 nmol/L. Patients with a raised level had more cardiovascular disease than those without (34% against 25.1%). These were people their doctors chose to test, so the figures describe a hospital group rather than the whole country.

In INTERHEART's analysis of Lp(a) across seven ethnic groups, which included 1,352 Arab participants, levels varied widely between groups, and the share of heart attacks linked to a high Lp(a) was largest among South Asians, at 9.5%.

Lipoprotein(a) test price in the UAE

When we read public prices on 11 October 2026, we did not find Lp(a) sold on its own at the UAE providers we checked. It appeared inside two broader packages, priced at 1,100 and 1,896, each with a lipid profile and other tests. A standard lipid profile, which does not include Lp(a), cost from 89 to 199 at six UAE providers. VAT was rarely stated, and home collection can add a fee.

Related tests

Lp(a) is read with Apolipoprotein B (ApoB), LDL Cholesterol and Non-HDL Cholesterol. The article ApoB: the cholesterol number most UAE panels skip explains how Lp(a) and ApoB fit together.

Why one Lp(a) result usually lasts

Unlike most markers, Lp(a) rarely needs rechecking. The 2026 US guideline says repeat testing is generally not needed, and the European consensus reserves a repeat for situations such as kidney or liver disease or acute infection. When two results differ a lot, the questions are whether a different assay or unit was used, or whether one of those conditions, or a pregnancy, was present. Over time, Lp(a) is the fixed backdrop for reading the numbers that do move, such as LDL and ApoB. Clare is opening with a waitlist at clare.health.